Aspira Women's Health Inc (AWH) - יחס חוב לטווח ארוך להון

The historical price chart for Aspira Women's Health (AWH) demonstrates the dynamics of a company whose growth is fueled by sales of OvaSuite systems for early oncology detection, with the indicator standing at 0.00. The business generates revenue from biomarker analysis in gynecology, aiding in the diagnosis of ovarian cancer. Thanks to cloud data processing and AI testing, scaling services requires no capital expenditures, which significantly optimizes the cost of each procedure.

Aspira Women's Health requires balanced financing to scale its biochemical testing network. The ratio compares liabilities with a maturity of more than one year to the amount of equity. By analyzing the proportion of long-term debt to equity, an investor assesses the degree of financial leverage. Excessive debt creates the risk of overpaying on interest. An optimal balance ensures sustainable development without losing control over assets.